EQS-Adhoc
LifeWatch AG: BioTelemetry, Inc. Launches a Tender Offer to Acquire LifeWatch AG - Seite 3
Press Conference
BioTelemetry and LifeWatch will conduct a joint press conference tomorrow, April 10, 2017, at 09:00 CEST or 03:00 AM Eastern Time. The press conference will occur at Convention Point, Selnaustrasse
30, CH-8001 Zurich, Switzerland. Accredited members of the media and analysts are invited to attend in person. There will also be a live audio webcast of the press conference which will be archived
on the companies' websites for approximately two weeks. The live audio webcast can be found under the following link: http://lifewatch100417-live.audio-webcast.com (login: lifewatch0417).
Dial-in numbers to join the live audio webcasts are detailed below:
Lesen Sie auch
CH: +41225805970
DE: +4969222229043
UK: +442030092452
USA: +18554027766
Participant PIN code: 60170589#
For further questions:
LifeWatch AG, Andrew Moore, CFO
c/o Communicators AG , Ralph Spillmann
Mobile: +41 79 514 64 84
E-Mail: investor-relations@lifewatch.com
About LifeWatch AG
LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE), Switzerland, is a leading healthcare technology and solution company, specializing in advanced digital health systems and
wireless remote diagnostic patient monitoring services. LifeWatch's services provide physicians with critical information to determine appropriate treatment and thereby improve patient outcomes.
LifeWatch AG has operative subsidiaries in the United States, in Switzerland, Israel and Turkey, and is the parent company of LifeWatch Services Inc., LifeWatch Technologies, Ltd. and LifeWatch
Turkey Holding AG (joint venture). LifeWatch Services, Inc. is a leading U.S.-based provider of cardiac monitoring services. LifeWatch Technologies Ltd., based in Israel, is a leading manufacturer
of digital health products. LifeWatch Sağlık Hizmetlerine A.S. is the operative Turkish subsidiary of LifeWatch Turkey Holding AG and provider of mobile cardiac telemetry services in Turkey. For
additional information, please visit www.lifewatch.com.